Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.gujaratterce.com | |
Market Cap | 48.08 Cr. | |
Enterprise Value(EV) | 52.53 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.68 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 95.39 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.97 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 8.85 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 7.32 | Calculated using Price: 64.79 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.74 Cr. | 7,420,300 Shares |
FaceValue | 10 | |
About Gujarat Terce Laboratories Ltd. | ||
Gujarat Terce Laboratories is engaged in the manufacturing of tablets, capsules, syrup and injections pertaining to the product group, pharmaceutical formulations and ayurvedic medicines. The company is selling its product in the domestic as well as international market. |
1 Day |
|
-2.00% |
1 Week |
|
+1.71% |
1 Month |
|
+41.62% |
3 Month |
|
+95.44% |
6 Month |
|
+208.38% |
1 Year |
|
+224.76% |
2 Year |
|
+106.01% |
5 Year |
|
+644.71% |
10 Year |
|
+625.53% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0.83 | -6.3 | -0.15 | 2.65 | 4.07 | 2.52 | -26.85 | 10.77 | -21.71 | |
Return on Capital Employed (%) | 3.62 | 0.88 | 1.93 | 3.96 | 5.38 | 5.77 | -16.4 | 8.31 | -14.81 | |
Return on Assets (%) | 0.35 | -2.66 | -0.06 | 1.26 | 2.23 | 1.33 | -11.44 | 3.58 | -6.18 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 11 | 10 | 10 | 10 | 11 | 11 | 8 | 9 | 7 | 6 | |
Non Curr. Liab. | 8 | 8 | 8 | 2 | 2 | 2 | 2 | 5 | 4 | 4 | |
Curr. Liab. | 8 | 7 | 6 | 7 | 7 | 9 | 12 | 13 | 17 | 14 | |
Minority Int. | |||||||||||
Equity & Liab. | 26 | 24 | 24 | 19 | 19 | 22 | 22 | 27 | 27 | 24 | |
Non Curr. Assets | 10 | 10 | 11 | 10 | 10 | 10 | 10 | 12 | 11 | 11 | |
Curr. Assets | 17 | 15 | 13 | 10 | 9 | 12 | 12 | 15 | 16 | 13 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 26 | 24 | 24 | 19 | 19 | 22 | 22 | 27 | 27 | 24 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 26 | 25 | 25 | 29 | 31 | 38 | 25 | 40 | 47 | 49 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
Total Income | 27 | 25 | 26 | 29 | 31 | 38 | 26 | 40 | 47 | 49 | |
Total Expenditure | -26 | -25 | -25 | -29 | -31 | -37 | -28 | -39 | -49 | -49 | |
PBIDT | 1 | 0 | 1 | 1 | 1 | 1 | -2 | 1 | -2 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
Exceptional Items | |||||||||||
PAT | 0 | -1 | 0 | 0 | 0 | 0 | -3 | 1 | -2 | 1 | |
Adjusted EPS | 0 | -1 | 0 | 0 | 1 | 0 | -3 | 1 | -2 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 1 | 0 | 0 | 5 | -1 | -2 | 0 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -2 | 1 | |
Cash Fr. Finan. | -1 | -1 | -1 | 0 | -5 | 0 | 2 | 2 | 2 | 0 | |
Net Change | -1 | 1 | -1 | 0 | 0 | -1 | 0 | 1 | -1 | 1 | |
Cash & Cash Eqvt | 1 | 2 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 2 |
Thu, 25 Apr 2024
Shareholder Meeting / Postal Ballot-Outcome of EGM Summary of Proceedings of the Extraordinary General Meeting of the Company held on Thursday April 25 2024 from 10:00 hrs to 10:25 hrs through Video Conference. |
Thu, 25 Apr 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report Scrutinizers Report for the Extraordinary General Meeting conducted on Thursday 25th April 2024 through video conferencing. |
Fri, 19 Apr 2024
Submission Of Certificate Under Requlation 40(9) Of SEBI (LODR) Regulations 2015 For The Year Ended On March 31 2024 Certificate Pursuant to regulation 40(9) of SEBI (LODR) Regulations 2015 duly certified by Mr. Gautam Virsadiya PCS for the year ended on 31st March 2024. |
Fri, 26 Apr 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Opening at High |
Opening at Low |